Naturally derived materials-based cell and drug delivery systems in skin regeneration

Journal of Controlled Release

Volumn 142, Issue 2, 2010, Pages 149-159

  Huang, Sha ^a   Fu, Xiaobing ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Cell; Delivery vehicle; Growth factor; Materials; Tissue engineering

Indexed keywords

ARTIFICIAL EXTRACELLULAR MATRIXES; CELL DELIVERY; CELLULAR INTERACTION; DELIVERY VEHICLE; DERIVED MATERIALS; DRUG DELIVERY SYSTEM; EXTRACELLULAR MATRICES; GROWTH FACTOR; GROWTH FACTOR DELIVERY; HEALING PROCESS; LOCAL ENVIRONMENTS; NATURAL MATERIALS; PROTEIN DELIVERY SYSTEMS; REGENERATIVE MEDICINE; SKIN REGENERATION; SYNTHETIC MATERIALS; TISSUE REGENERATION;

BIOACTIVITY; BIOPOLYMERS; DRUG DELIVERY; MATERIALS; PEPTIDES; TISSUE; TISSUE ENGINEERING;

GROWTH (MATERIALS);

ALGINIC ACID; BASIC FIBROBLAST GROWTH FACTOR; BIOMATERIAL; CHITOSAN; COLLAGEN; FIBRIN; FIBRIN GLUE; FIBRINOGEN; FIBRONECTIN; GELATIN; MICROSPHERE; TISSUE SCAFFOLD;

BIOCOMPATIBILITY; BIODEGRADABILITY; BIOMECHANICS; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSPLANTATION; DECUBITUS; DRUG DELIVERY SYSTEM; EQUIPMENT DESIGN; EXTRACELLULAR MATRIX; HUMAN; HYDROGEL; PRIORITY JOURNAL; REVIEW; SKIN DEFECT; SKIN GRAFT; TISSUE ENGINEERING; TISSUE REGENERATION; WOUND CLOSURE; WOUND DRESSING; WOUND HEALING;

ANIMALS; BIOCOMPATIBLE MATERIALS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; REGENERATIVE MEDICINE; SKIN; TISSUE ENGINEERING; VEHICLES;

EID: 76749098937     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.10.018     Document Type: Review

References (83)

1. Geetha Priya S., Jungvid H., Kumar A. Skin tissue engineering for tissue repair and regeneration. Tissue Eng. Part B Rev. 2008, 14:105-118.
2. Bannasch H., Föhn M., Unterberg T., Bach A.D., Weyand B., Stark G.B. Skin tissue engineering. Clin. Plast. Surg. 2003, 30:573-579.
3. Kim B.S., Baez C.E., Atala A. Biomaterials for tissue engineering. World J. Urol. 2000, 18:2-9.
4. Lavik E., Langer R. Tissue engineering: current state and perspectives. Appl. Microbiol. Biotechnol. 2004, 65:1-8.
5. Saltzman W.M., Olbricht W.L. Building drug delivery into tissue engineering. Nat. Rev. Drug. Discov. 2002, 1:177-186.
6. Tabata Y. Significance of biomaterials and drug delivery systems in tissue engineering. Connect. Tissue 2001, 33:315-324.
7. Guo X.D., Zheng Q.X., Du J.Y., Yang S.H., Wang H., Shao Z.W., Sun E.J. Molecular tissue engineering: concepts, status and challenge. J. Wuhan. Univ. Technol. 2002, 17:30-34.
8. Lee C.H., Singla A., Lee Y. Biomedical applications of collagen. Int. J. Pharmacogn. 2001, 221:1-22.
9. Ikada Y., Tabata Y. Protein release from gelatin matrices. Adv. Drug Deliv. Rev. 1998, 31:287-301.
10. Yamamoto M., Yanase K., Tabata Y. Fabrication of three dimensional cell scaffolds with spatial gradients of biomolecules. Inflamm. Regen 2007, 27:102-106.
11. Payne R.G., McGonigle J.S., Yaszemski M.J., Yasko A.W., Mikos A.G. Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 3. Proliferation and differentiation of encapsulated marrow stromal osteoblasts cultured on crosslinking poly(propylene fumarate). Biomaterials 2002, 23:4381-4387.
12. Huang S., Deng T., Wang Y., Deng Z., He L., Liu S., Yang J., Jin Y. Multifunctional implantable particles for skin tissue regeneration: preparation, characterization, in vitro and in vivo studies. Acta Biomater. 2008, 4:1057-1066.
13. Makarand R. Tissue engineering: implications in the treatment of organ and tissue defects. Biogerontology 2001, 2:117-125.
14. Shin H., Jo S., Mikos A.G. Biomimetic materials for tissue engineering. Biomaterials 2003, 24:4353-4364.
15. Chunlin Y., Hillas P.J., Buez J.A., Nokelainen M., Balan J., Tang J., Spiro R., Polarek J.W. The application of recombinant human collagen in tissue engineering. BioDrugs 2004, 18:103-119.
16. Klein B., Schiffer R., Hafemann B., Klosterhalfen B., Zwadlo-Klarwasser G. Inflammatory response to a porcine membrane composed of fibrous collagen and elastin as dermal substitute. J. Mater. Sci. Mater. Med. 2001, 12:419-424.
17. Marston W.A., Usala A., Hill R.S., Mendes R., Minsley MA. Initial report of the use of an injectable porcine collagen-derived matrix to stimulate healing of diabetic foot wounds in humans. Wound. Repair. Regen 2005, 13:243-247.
18. Friess W. Collagen: biomaterial for drug delivery. Eur. J. Pharm. Biopharm. 1998, 45:113-136.
19. Chen G.P., Ushida T., Tateishi T. Hybrid biomaterials for tissue engineering: a preparative method for PLA or PLGA-collagen hybrid sponges. Adv. Mater. 2000, 12:455-467.
20. Pieper J., Hafmans T., Van Wachem P., Van Luyn M., Brouwer L., Veerkamp J., Kuppevelt T. Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue regeneration in rats. J. Biomed. Mater. Res. 2002, 62:185-194.
21. Lynn A.K., Yannas I.V., Bonfield W. Antigenicity and immunogenicity of collagen. J. Biomed. Mater. Res. B Appl. Biomater. 2004, 71B:343-354.
22. Simionescu D.T., Lu Q., Song Y., Lee J.S., Rosenbalm T.N., Kelley C., Vyavahare N.R. Biocompatibility and remodeling potential of pure arterial elastin and collagen scaffolds. Biomaterials 2006, 27:702-713.
23. Sachlos E., Reis N., Czernuszka J.T., Ainsley C., Derby B. Novel collagen scaffolds with predefined internal morphology made by solid freeform fabrication. Biomaterials 2003, 24:1487-1497.
24. Rusz D., Olsen C., Yang M., Bodo R., Chang S., Leigh J., Baez D., Carmichael M., Perala E., Hamalainen R., Jarvinen M., Polarek J. Recombinant collagen and gelatin for drug delivery. Adv. Drug. Deliv. Rev. 2003, 55:1547-1567.
25. Tanaka A., Nagate T., Matsuda H. Acceleration of wound healing by gelatin film dressings with epidermal growth factor. J. Vet. Med. Sci. 2005, 67:909-913.
26. Tabata Y, Ikada Y Protein release from gelatin matrices. Adv. Drug. Deliv. Rev. 1998, 31:287-301.
27. Ito A., Mase A., Takizawa Y., Shinkai M., Honda H., Hata K-I., Ueda M., Kobayashi T. Transglutaminase-mediated gelatin matrices incorporating cell adhesion factors as a biomaterial for tissue engineering. J. Biosci. Bioeng. 2003, 95:196-199.
28. Tabata Y., Hijikata S., Ikada Y. Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels. J. Control. Release 1994, 31:89-199.
29. Djagny K.B., Wang Z., Xu S. Gelatin: a valuable protein for food and pharmaceutical industries: review. Crit. Rev. Food Sci. Nutr. 2001, 41:481-492.
30. Kuijpers A.J., Engbers G.H., Krijgsveld J., Zaat S.A., Dankert J., Feijen J. Cross-linking and characterisation of gelatin matrices for biomedical applications. J. Biomater. Sci. Polym. Ed. 2000, 11:225-243.
31. Kang H.W., Tabata Y., Ikada Y. Fabrication of porous gelatin scaffolds for tissue engineering. Biomaterials 1999, 20:1339-1344.
32. Tabata Y., Hijikata S., Muniruzzaman M., Ikada Y. Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor. J. Biomater. Sci. Polym. Ed. 1999, 10:79-94.
33. Holland T.A., Tabata Y., Mikos A.G. In vitro release of transforming growth factor-beta1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. J. Control. Release 2003, 91:299-313.
34. Holland T.A., Tabata Y., Mikos A.G. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J. Control. Release 2005, 101:111-125.
35. Kimura Y., Ozeki M., Inamoto T., Tabata Y. Adipose tissue engineering based on human preadipocytes combined with gelatin microspheres containing basic fibroblast growth factor. Biomaterials 2003, 24:2513-2521.
36. Iwanaga K., Yabuta T., Kakemi M., Morimoto K., Tabata Y., Ikada Y. Usefulness of microspheres composed of gelatin with various cross-linking density. J. Microencapsul. 2003, 20:767-776.
37. Kimura Y., Ozeki M., Inamoto T., Tabata Y. Time course of de novo adipogenesis in matrigel by gelatin microspheres incorporating basic fibroblast growth factor. Tissue Eng. 2002, 8:603-613.
38. Wolberg A.S. Thrombin generation and fibrin clot structure. Blood Rev. 2007, 21:131-142.
39. Le Nihouannen D., Guehennec L.L., Rouillon T., Pilet P., Bilban M., Layrolle P., Daculsi G. Micro-architecture of calcium phosphate granules and fibrin glue composites for bone tissue engineering. Biomaterials 2006, 27:2716-2722.
40. Oju J., Soo Hyun R., Ji Hyung C., Kim B.-S. Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. J. Control. Release 2005, 105:249-259.
41. Jimenez P.A., Jimenez S.E. Tissue and cellular approaches to wound repair. Am. J. Surg. 2004, 187:56S-64S.
42. Bensaid W., Triffitt J.T., Blanchat C., Oudina K., Sedel L., Petite H. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 2003, 24:2497-2502.
43. Wechselberger G., Russell R., Neumeister M., Schoeller T., Piza-Katzer H., Rainer C. Successful transplantation of three tissue-engineered cell types using capsule induction technique and fibrin glue as a delivery vehicle. Plastic Reconst. Surg. 2002, 110:123-129.
44. Rowe S.L., Lee S., Stegemann J.P. Influence of thrombin concentration on the mechanical and morphological properties of cell-seeded fibrin hydrogels. Acta Biomater. 2007, 3:59-67.
45. Miller E.D., Fisher G.W., Weiss L.E., Walker L.M., Campbell P.G. Dosedependent cell growth in response to concentration modulated patterns of FGF-2 printed on fibrin. Biomaterials 2006, 27:2213-2221.
46. Perka C., Schultz O., Lindenhayn K., Spitzer R.S., Muschik M., Sittinger M., Burmester G.R. Joint cartilage repair with transplantation of embryonic chondrocytes embedded in collagen-fibrin matrices. Clin. Exper. Rheumatol. 2000, 18:13-22.
47. George M., Abraham T.E. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan - a review. J. Control. Release 2006, 114:1-14.
48. Paul W., Sharma C.P. Chitosan and alginate wound dressings: a short review. Trends Biomater. Artif. Organs. 2004, 18:18-23.
49. Kuo C.K., Ma P.X. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: part 1. Structure, gelation rate and mechanical properties. Biomaterials 2001, 22:511-521.
50. Perets A., Baruch Y., Weisbuch F., Shoshany G., Neufeld G., Cohen S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J. Biomed. Mater. Res. A 2003, 65:489-497.
51. Weber W., Rinderknecht M., Baba MD-E., de Glutz F-N., Aubel D., Fussenegger M. CellMAC: a novel technology for encapsulation of mammalian cells in cellulose sulfate/pDADMAC capsules assembled on a transient alginate/Ca2+ scaffold. J. Biotechnol. 2004, 114:315-326.
52. Azad A.K., Sermsintham N., Chandrkrachang S., Stevens W.F. Chitosan membrane as a wound healing dressing: characterization and clinical application. J. Biomed. Mater. Res. Part B Appl. Biomater. B 2004, 69:216-222.
53. Park Y.J., Lee Y.M., Lee J.Y., Seol Y.J., Chung C.P., Lee S.J. Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration. J. Control. Release 2000, 67:385-394.
54. Nakamatsu J., Torres F.G., Troncoso O.P., Yuan M.L., Boccaccini A.R. Processing and characterization of porous structures from chitosan and starch for tissue engineering scaffolds. Biomacromolecules. 2006, 7:3345-3355.
55. Okamoto Y., Yano R., Miyatake K., Tomohiro I., Shigemasa Y., Minami S. Effects of chitin and chitosan on blood coagulation. Carbohyd. Polym. 2003, 53:337-342.
56. Kweon D.K., Song S.B., Park Y.Y. Preparation of water-soluble chitosan/heparin complex and its application as wound healing accelerator. Biomaterials 2003, 24:1595-1601.
57. Alemdaroglu C., Degim Z., Celebi N., Zor F., Ozturk S., Erdogan D. An investigation on burn wound healing in rats with chitosan gel formulation containing epidermal growth factor. Burns 2006, 32:319-327.
58. VandeWitte P., Dijkstra P.J., VandenBerg J.W.A., Feijen J. Phase separation processes in polymer solutions in relation to membrane formation. J. Memb. Sci. 1996, 117:1-31.
59. Jin Y.J., Park T.G. Degradation behaviors of biodegradable macroporous scaffolds prepared by gas foaming of effervescent salts. Biomed. Mater. Res. 2001, 55:401-408.
60. Levesque S.G., Lim R.M., Shoichet M.S. Macroporous interconnected dextran scaffolds of controlled porosity for tissue-engineering applications. Biomaterials 2005, 26:7436-7446.
61. Huang S., Wang Y., Deng T., Jin F., Liu S., Zhang Y., Feng F., Jin Y. Facile modification of gelatin-based microcarriers with multiporous surface and proliferative growth factors delivery to enhance cell growth. J. Alloy. Compd. 2008, 460:639-645.
62. Clark R.A.F., Singer A.J. Wound repair: basic biology to tissue engineering. Principles of Tissue Engineering 2000, Academic Press, London. R. Lanza, R. Langer, J.P. Vacanti (Eds.).
63. Bradley M., Cullum N., Nelson E.A., Petticrew M., Sheldon T., Torgerson D. Systematic reviews of wound care management: (2) dressings and topical agents used in the healing of chronic wounds. Health Technol. Assess. 1999, 3:1-47.
64. Huang S., Zhang Y., Tang L., Deng Z., Lu W., Feng F., Xu X., Jin Y. Functional bilayered skin substitute constructed by tissue-engineered extracellular matrix and microsphere-incorporated gelatin hydrogel for wound repair. Tissue Eng. Part. A 2009, 15:2617.
65. Lee J.E., Park J.C., Lee H.K., Oh S.H., Suh H. Laminin modified infection-preventing collagen membrane containing silver sulfadiazine-hyaluronan microparticles. Artif. Organs 2002, 26:521-528.
66. Sripriya R., Kumar M.S., Sehgal P.K. Improved collagen bilayer dressing for the controlled release of drugs. J. Biomed. Mater. Res. Part B Appl. Biomater. B. 2004, 70:389-396.
67. Yun Y.H., Goetz D.J., Yellen P., Chen W.L. Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials 2004, 25:147-157.
68. Panyam J., Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug. Deliv. Rev. 2003, 55:329-347.
69. Younga S., Wongb M., Tabatac Y., Mikos A.G. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J. Control. Release 2005, 109:256-274.
70. Patel Z.S., Mikos A.G. Angiogenesis with biomaterial-based drug- and cell-delivery systems. J. Biomater. Sci. Polym. Ed. 2004, 15:701-726.
71. Qiu Q., Ducheyne P., Gao H., Ayyaswamy P. Formation and differentiation of three-dimensional rat marrow stromal cell culture on microcarriers in a rotating-wall vessel. Tissue Eng. 1998, 4:19-34.
72. Park C.J., Clark S.G., Lichtensteiger C.A., Jamison R.D., Johnson A.J. Accelerated wound closure of pressure ulcers in aged mice by chitosan scaffolds with and without bFGF. Acta Biomater. 2009, 5:1926-1936.
73. Gu F., Amsden B., Neufeld R. Sustained delivery of vascular endothelial growth factor with alginate beads. J. Control. Release 2004, 96:463-472.
74. Nof M., Shea L.D. Drug-releasing scaffolds fabricated from drug-loaded microspheres. J. Biomed. Mater. Res. 2002, 59:349-356.
75. Hoffman A.S. Hydrogels for biomedical applications. Adv. Drug. Deliv. Rev. 2002, 43:3-12.
76. Augst A.D., Kong H.J., Mooney D.J. Alginate hydrogels as biomaterials. Macromol. Biosci. 2006, 6:623-633.
77. Molinaro G., Leroux J-C., Damas J., Adam A. Biocompatibility of thermosensitive chitosan-based hydrogels: an in vivo experimental approach to injectable biomaterials. Biomaterials 2002, 23:2717-2722.
78. Kurisawa M., Yui N. Gelatin/dextran intelligent hydrogels for drug delivery: dual-stimuli-responsive degradation in relation to miscibility in interpenetrating polymer networks. J. Control. Release 1998, 199:1547-1554.
79. Leach J.B., Bivens K.A., Patrick C.W., Schmidt C.E. Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds. Biotechnol. Bioeng. 2003, 82:578-589.
80. Liu Y., Cai S., Shu X.Z., Shelby J., Prestwich GD Release of basic fibroblast growth factor from a crosslinked glycosaminoglycan hydrogel promotes wound healing. Wound. Repair. Regen. 2007, 15:245-251.
81. Ito H., Steplewski A., Alabyeva T., Fertala A. Testing the utility of rationally engineered recombinant collagen-like proteins for applications in tissue engineering. Biomed. Mater. Res. A 2006, 76:551-560.
82. Burdick J.A., Chung C., Jia X., Randolph M.A., Langer R. Controlled degradation and mechanical behavior of photopolymerized hyaluronic acid networks. Biomacromolecules 2005, 6:386-391.
83. de Leeuw J., de Vijlder H.C., Bjerring P., Neumann H.A. Liposomes in dermatology today. J. Eur. Acad. Dermatol. Venereol. 2009, 23:505-516.